221 related articles for article (PubMed ID: 29517989)
1. Coordinated Regulation of Metabolic Transporters and Migration/Invasion by Carbonic Anhydrase IX.
McDonald PC; Swayampakula M; Dedhar S
Metabolites; 2018 Mar; 8(1):. PubMed ID: 29517989
[TBL] [Abstract][Full Text] [Related]
2. Interplay of Carbonic Anhydrase IX With Amino Acid and Acid/Base Transporters in the Hypoxic Tumor Microenvironment.
Venkateswaran G; Dedhar S
Front Cell Dev Biol; 2020; 8():602668. PubMed ID: 33240897
[TBL] [Abstract][Full Text] [Related]
3. The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion.
Swayampakula M; McDonald PC; Vallejo M; Coyaud E; Chafe SC; Westerback A; Venkateswaran G; Shankar J; Gao G; Laurent EMN; Lou Y; Bennewith KL; Supuran CT; Nabi IR; Raught B; Dedhar S
Oncogene; 2017 Nov; 36(45):6244-6261. PubMed ID: 28692057
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.
Chiche J; Ilc K; Laferrière J; Trottier E; Dayan F; Mazure NM; Brahimi-Horn MC; Pouysségur J
Cancer Res; 2009 Jan; 69(1):358-68. PubMed ID: 19118021
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.
Andreucci E; Peppicelli S; Carta F; Brisotto G; Biscontin E; Ruzzolini J; Bianchini F; Biagioni A; Supuran CT; Calorini L
J Mol Med (Berl); 2017 Dec; 95(12):1341-1353. PubMed ID: 28929255
[TBL] [Abstract][Full Text] [Related]
6. Renewed interests in carbonic anhydrase IX in relevance to breast cancer treatment.
Dolatkhah M; Omidi Y
Bioimpacts; 2019; 9(4):195-197. PubMed ID: 31799155
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
9. Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside.
McDonald PC; Chafe SC; Supuran CT; Dedhar S
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884358
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX.
Lenferink AEG; McDonald PC; Cantin C; Grothé S; Gosselin M; Baardsnes J; Banville M; Lachance P; Robert A; Cepero-Donates Y; Radinovic S; Salois P; Parat M; Oamari H; Dulude A; Patel M; Lafrance M; Acel A; Bousquet-Gagnon N; L'Abbé D; Pelletier A; Malenfant F; Jaramillo M; O'Connor-Mccourt M; Wu C; Durocher Y; Duchesne M; Gadoury C; Marcil A; Fortin Y; Paul-Roc B; Acchione M; Chafe SC; Nemirovsky O; Lau J; Bénard F; Dedhar S
MAbs; 2021; 13(1):1999194. PubMed ID: 34806527
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
[TBL] [Abstract][Full Text] [Related]
12. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
13. Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness.
Ward C; Meehan J; Gray M; Kunkler IH; Langdon SP; Argyle DJ
Metabolites; 2018 Feb; 8(1):. PubMed ID: 29439394
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
Chen Z; Ai L; Mboge MY; Tu C; McKenna R; Brown KD; Heldermon CD; Frost SC
PLoS One; 2018; 13(7):e0199476. PubMed ID: 29965974
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells.
McDonald PC; Dedhar S
Subcell Biochem; 2014; 75():255-69. PubMed ID: 24146383
[TBL] [Abstract][Full Text] [Related]
16. Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients.
Ilie M; Hofman V; Zangari J; Chiche J; Mouroux J; Mazure NM; Pouysségur J; Brest P; Hofman P
Lung Cancer; 2013 Oct; 82(1):16-23. PubMed ID: 23910904
[TBL] [Abstract][Full Text] [Related]
17. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
Robertson N; Potter C; Harris AL
Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400
[TBL] [Abstract][Full Text] [Related]
18. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction.
McDonald PC; Chafe SC; Dedhar S
Front Cell Dev Biol; 2016; 4():27. PubMed ID: 27066484
[TBL] [Abstract][Full Text] [Related]
19. Co-vulnerabilities of inhibiting carbonic anhydrase IX in ferroptosis-mediated tumor cell death.
McDonald PC; Dedhar S
Front Mol Biosci; 2023; 10():1327310. PubMed ID: 38099193
[TBL] [Abstract][Full Text] [Related]
20. SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration.
Eloranta K; Pihlajoki M; Liljeström E; Nousiainen R; Soini T; Lohi J; Cairo S; Wilson DB; Parkkila S; Heikinheimo M
Front Oncol; 2023; 13():1118268. PubMed ID: 36776327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
